Supplement encyclopedia

Crocus sativus

Saffron is a spice made from the dried stigmas of Crocus sativus, also used to produce extracts.

Double-check the conclusions and read the sources before choosing a supplement.

Main conclusion

What it may offer

  • Safr’Inside extract may slightly improve self-rated sleep in adults with moderate insomnia symptoms. Over four weeks, symptoms in the pooled 20 and 30 mg a day groups decreased by about one point more than with placebo.
  • At 20 mg a day, self-rated sleep quality after four weeks was 1.02 points higher than placebo, and at 30 mg it was 0.82 points higher. These separate comparisons with placebo show small improvements, not an advantage of one dose over the other.
  • In adults with persistent depressive symptoms while taking an antidepressant, adding affron at 14 mg twice a day for eight weeks reduced clinician-rated symptoms more than placebo. There was no advantage in participants' own ratings.
  • In adults with mild depressive symptoms, Activ’Inside at 15 mg twice a day for six weeks showed no advantage over placebo for low mood, anxiety or fatigue.
  • Women with sexual difficulties taking 15 mg of saffron twice a day for six weeks rated desire, lubrication and satisfaction higher than women taking placebo. The overall sexual function result was less clear.
  • Saffron capsules at 28–30 mg a day for two to three menstrual cycles may ease PMS symptoms. A review of studies found this result for different preparations.
  • The menstrual pain result was unstable: the initial improvement in the review did not persist in an additional analysis. These studies used different capsules at 28, 75 or 90 mg a day for three menstrual cycles.

[1] [2] [3] [4] [5]

What was studied

  • The three sleep results come from one study: of 165 adults with moderate insomnia symptoms, 150 completed four weeks. When assessing the evidence, count this as one test of the extract, not three independent studies.
  • The study tested 20 or 30 mg of Safr’Inside extract a day about an hour before bed for four weeks against maltodextrin placebo. This regimen allows comparison of a specific supplement's composition and use with those studied.
  • Mood and sexual function were tested in separate trials of specific capsules: Activ’Inside, affron and Crocus sativus. Results concern the groups and regimens described.
  • PMS and menstrual pain data come from one review of different capsules and regimens. It included studies with different control conditions, including one without placebo.

[1] [2] [3] [4] [5]

Which forms were considered

  • Saffron as a spice is the dried stigmas of Crocus sativus. This is the spice used in cooking.
  • Sleep improvement was studied with standardised Safr’Inside extract at 20 or 30 mg a day, not the culinary spice. When choosing a supplement, match the extract's name and composition to the product studied.

[1] [2]

How to get it from food

  • Saffron can be added to dishes for colour and aroma. This is food use of the dried stigmas of Crocus sativus.
  • According to USDA, a teaspoon of dried saffron weighs 0.7 g and provides about 2.2 kcal. These values help estimate the amount of spice in food; they do not specify a standardised extract dose.

[1] [2] [3]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Athens Insomnia Scale AISAfter four weeks, AIS sleep symptoms decreased by 0.95 points more than with placebo when pooling the 20 and 30 mg/day Safr’Inside groups.Adjusted AIS difference for pooled 20 and 30 mg versus placebo −0.95 points (95% CI −1.79…−0.11), p=0.027; mean changes −1.54 and −1.96 versus −0.71.
2/4 LowPrecision of the estimate: Short follow-up and uncertain clinical relevance of the magnitude. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The measurement directly answers the specific narrow study question. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Subjective outcomes, attrition, secondary comparisons.
11 trialEffect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗165 adults with moderate insomnia symptoms, 150 completed
  1. Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗
Single-item Sleep Quality Scale SQSAfter four weeks, self-rated SQS sleep quality was 1.02 points higher with 20 mg/day Safr’Inside than with placebo.At week 4, adjusted SQS contrast +1.02 points (95% CI +0.43…+1.62), p<0.001 for 20 mg versus placebo.
2/4 LowPrecision of the estimate: Short follow-up and uncertain clinical relevance of the magnitude. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The measurement directly answers the specific narrow study question. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Subjective outcomes, attrition, secondary comparisons.
11 trialEffect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗165 adults with moderate insomnia symptoms, 150 completed
  1. Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗
Single-item Sleep Quality Scale SQSAfter four weeks, self-rated SQS sleep quality was 0.82 points higher with 30 mg/day Safr’Inside than with placebo.At week 4, adjusted SQS contrast +0.82 points (95% CI +0.22…+1.41), p=0.004 for 30 mg versus placebo.
2/4 LowPrecision of the estimate: Short follow-up and uncertain clinical relevance of the magnitude. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The measurement directly answers the specific narrow study question. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Subjective outcomes, attrition, secondary comparisons.
11 trialEffect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗165 adults with moderate insomnia symptoms, 150 completed
  1. Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextInformation
Intake and studied regimensThe sleep study used 20 or 30 mg of standardised Safr’Inside extract a day about an hour before bed for four weeks; these milligrams concern extract, not saffron spice.

Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗

Forms

Saffron is the dried stigmas of Crocus sativus. The spice, standardised Safr’Inside extract and individual saffron compounds differ in composition; the RCT result concerns the extract studied.

Guidance for each goal

Athens Insomnia Scale AIS2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: Short follow-up and uncertain clinical relevance of the magnitude. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The measurement directly answers the specific narrow study question. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Subjective outcomes, attrition, secondary comparisons.

After four weeks, AIS sleep symptoms decreased by 0.95 points more than with placebo when pooling the 20 and 30 mg/day Safr’Inside groups.

Study findings. After four weeks, AIS sleep symptoms decreased by 0.95 points more than with placebo when pooling the 20 and 30 mg/day Safr’Inside groups.

Studied regimen20 or 30 mg/day, pooled active groupsStandardised oral Safr’Inside extract about an hour before bed
Duration and population4 weeks165 adults with moderate insomnia symptoms, 150 completed

Comparison: Maltodextrin

Single-item Sleep Quality Scale SQS2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: Short follow-up and uncertain clinical relevance of the magnitude. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The measurement directly answers the specific narrow study question. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Subjective outcomes, attrition, secondary comparisons.

After four weeks, self-rated SQS sleep quality was 1.02 points higher with 20 mg/day Safr’Inside than with placebo.

Study findings. After four weeks, self-rated SQS sleep quality was 1.02 points higher with 20 mg/day Safr’Inside than with placebo.

Studied regimen20 mg/dayStandardised oral Safr’Inside extract about an hour before bed
Duration and population4 weeks165 adults with moderate insomnia symptoms, 150 completed

Comparison: Maltodextrin

Single-item Sleep Quality Scale SQS2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: Short follow-up and uncertain clinical relevance of the magnitude. Consistency of results: There are no grounds for a separate downgrade. Applicability to the stated group: The measurement directly answers the specific narrow study question. Possible publication bias: There are no specific data for a separate downgrade. Study methods: Subjective outcomes, attrition, secondary comparisons.

After four weeks, self-rated SQS sleep quality was 0.82 points higher with 30 mg/day Safr’Inside than with placebo.

Study findings. After four weeks, self-rated SQS sleep quality was 0.82 points higher with 30 mg/day Safr’Inside than with placebo.

Studied regimen30 mg/dayStandardised oral Safr’Inside extract about an hour before bed
Duration and population4 weeks165 adults with moderate insomnia symptoms, 150 completed

Comparison: Maltodextrin

Mood, anxiety and fatigue with mild symptoms2/4 LowRead moreCollapse
Confidence
2/4 Lowrisk_of_bias: Several outcomes and self-ratings. inconsistency: There are no grounds for a separate downgrade. indirectness: The measurement directly answers the specific narrow PICO. imprecision: 51 participants; exact CI of the comparative effect not confirmed. publication_bias: There are no specific data for a separate downgrade.

Activ’Inside showed no advantage over placebo in the overall score for low mood, anxiety and fatigue or its individual components.

Study findings. Activ’Inside showed no advantage over placebo in the overall score for low mood, anxiety and fatigue or its individual components.

Studied regimen15 mg twice/day with breakfast and dinnerActiv’Inside extract, >2.5% crocins and >1.5% safranal by the stated different analytical methods
Duration and population6 weeks51 adults with subclinical depressive symptoms

Comparison: Maltodextrin

Depressive symptoms: clinician rating with added affron1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Attrition and differing results on two primary scales. inconsistency: There are no grounds for a separate downgrade. indirectness: Only adjunct use of the formulation studied in the clinical group. imprecision: One experiment, incomplete precision of the estimate. publication_bias: There are no specific data for a separate downgrade.

Adding affron to an antidepressant reduced clinician-rated depressive symptoms more.

Study findings. Adding affron to an antidepressant reduced clinician-rated depressive symptoms more.

Studied regimen14 mg twice/dayStandardised affron as an adjunct to an antidepressant
Duration and population8 weeks160 adults with persistent depressive symptoms on an antidepressant; 139 with usable data

Comparison: Placebo alongside an antidepressant

Depressive symptoms: self-rating with added affron1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Attrition and differing results on two primary scales. inconsistency: There are no grounds for a separate downgrade. indirectness: Only adjunct use of the formulation studied in the clinical group. imprecision: One experiment, incomplete precision of the estimate. publication_bias: There are no specific data for a separate downgrade.

Adding affron to an antidepressant showed no advantage in participants' own symptom ratings.

Study findings. Adding affron to an antidepressant showed no advantage in participants' own symptom ratings.

Studied regimen14 mg twice/dayStandardised affron as an adjunct to an antidepressant
Duration and population8 weeks160 adults with persistent depressive symptoms on an antidepressant; 139 with usable data

Comparison: Placebo alongside an antidepressant

Overall sexual function score1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Attrition and several subscale comparisons. inconsistency: There are no grounds for a separate downgrade. indirectness: Selected clinical group, limited transfer to overall well-being. imprecision: Effect size with CI not confirmed. publication_bias: There are no specific data for a separate downgrade.

The overall sexual function score gave a borderline result.

Study findings. The overall sexual function score gave a borderline result.

Studied regimen15 mg twice/dayCrocus sativus capsules
Duration and population6 weeks74 women aged 18–55 with sexual dysfunction, 68 completed

Comparison: Placebo

Sexual desire1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Attrition and several subscale comparisons. inconsistency: There are no grounds for a separate downgrade. indirectness: Selected clinical group, limited transfer to overall well-being. imprecision: Effect size with CI not confirmed. publication_bias: There are no specific data for a separate downgrade.

In the study of women with sexual difficulties, desire ratings improved in favour of saffron.

Study findings. In the study of women with sexual difficulties, desire ratings improved in favour of saffron.

Studied regimen15 mg twice/dayCrocus sativus capsules
Duration and population6 weeks74 women aged 18–55 with sexual dysfunction, 68 completed

Comparison: Placebo

Lubrication during sexual activity1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Attrition and several subscale comparisons. inconsistency: There are no grounds for a separate downgrade. indirectness: Selected clinical group, limited transfer to overall well-being. imprecision: Effect size with CI not confirmed. publication_bias: There are no specific data for a separate downgrade.

In the study of women with sexual difficulties, lubrication ratings improved in favour of saffron.

Study findings. In the study of women with sexual difficulties, lubrication ratings improved in favour of saffron.

Studied regimen15 mg twice/dayCrocus sativus capsules
Duration and population6 weeks74 women aged 18–55 with sexual dysfunction, 68 completed

Comparison: Placebo

Satisfaction with sexual life1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Attrition and several subscale comparisons. inconsistency: There are no grounds for a separate downgrade. indirectness: Selected clinical group, limited transfer to overall well-being. imprecision: Effect size with CI not confirmed. publication_bias: There are no specific data for a separate downgrade.

In the study of women with sexual difficulties, satisfaction ratings improved in favour of saffron.

Study findings. In the study of women with sexual difficulties, satisfaction ratings improved in favour of saffron.

Studied regimen15 mg twice/dayCrocus sativus capsules
Duration and population6 weeks74 women aged 18–55 with sexual dysfunction, 68 completed

Comparison: Placebo

Overall PMS symptoms1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Mixed designs and quality limitations. inconsistency: Different scales and unstable estimates between analyses. indirectness: Different forms and control conditions. imprecision: Enough data for a limited conclusion. publication_bias: There are no specific data for a separate downgrade.

In the review of different saffron capsules, overall PMS symptom severity decreased.

Study findings. In the review of different saffron capsules, overall PMS symptom severity decreased.

Studied regimen28–30 mg/day: 30 mg/day in four studies and 28 mg/day in one.Oral saffron capsules of different preparations; no uniform composition standardisation.
Duration and population2–3 menstrual cycles according to the specific regimen.Women with PMS in the review's studies; ages and designs varied.

Comparison: Different placebos; one quasi-experimental study without placebo.

Menstrual pain1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowrisk_of_bias: Mixed designs and quality limitations. inconsistency: Different scales and unstable estimates between analyses. indirectness: Different forms and control conditions. imprecision: Enough data for a limited conclusion. publication_bias: There are no specific data for a separate downgrade.

The initial signal of reduced menstrual pain did not persist after correction for possible publication bias.

Study findings. The initial signal of reduced menstrual pain did not persist after correction for possible publication bias.

Studied regimen75 mg/day, 90 mg/day or 28 mg/day in different studies.Oral saffron capsules of different preparations; no uniform composition standardisation.
Duration and population3 menstrual cycles.Women with dysmenorrhoea in the review's studies; in Lopresti this is a secondary outcome.

Comparison: Different control capsules: compositions from table 1 retained separately; not a single uniform placebo.

Safety and limitations

Saffron studies reported gastrointestinal adverse events, usually mild; not all studies collected them systematically. Safety data for concentrated saffron supplements during pregnancy, breastfeeding and in children are insufficient; food use of the spice is considered separately.

Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗ · Saffron and Pregnancy: Cultural Practices, Beliefs, and Safety Evidence: An Integrative Review ↗ · Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence ↗

Interactions

WithEffectActionSource
RivaroxabanIn one reported case, bleeding occurred when rivaroxaban was combined with a saffron supplement; causality and frequency have not been established.Before taking a saffron supplement, discuss it with the doctor who prescribed the anticoagulant.Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence ↗

Food sources

Saffron is used in food as a spice. The weight of dried stigmas is not the dose of a standardised extract or individual compounds.

Saffron as a spice

Dried Crocus sativus stigmas are used for food colour and aroma; the spice differs in composition from a standardised extract.

CPG Sec 525.750 Spices - Definitions ↗
Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗

Food composition

FoodGroupAmountServingCaloriesSources
Saffrondried stigmas of Crocus sativusSpices100 g of dried saffron (spice weight) / 100 g0.7 g · 0.7 g of dried saffron (spice weight) · 2.17 kcalUSDA: 1 teaspoon of saffron is 0.7 g.310 kcal / 100 gUSDA National Nutrient Database for Standard Reference, Release 28 (2015) — food group 02 ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial ↗Athens Insomnia Scale AIS: Athens Insomnia Scale AIS Single-item Sleep Quality Scale SQS: Single-item Sleep Quality Scale SQSAthens Insomnia Scale AIS: 165 adults with moderate insomnia symptoms, 150 completed Single-item Sleep Quality Scale SQS: 165 adults with moderate insomnia symptoms, 150 completedAthens Insomnia Scale AIS: Standardised oral Safr’Inside extract about an hour before bed; 20 or 30 mg/day, pooled active groups; 4 weeks; comparison: Maltodextrin Single-item Sleep Quality Scale SQS: Standardised oral Safr’Inside extract about an hour before bed; 20 mg/day; 4 weeks; comparison: Maltodextrin Single-item Sleep Quality Scale SQS: Standardised oral Safr’Inside extract about an hour before bed; 30 mg/day; 4 weeks; comparison: MaltodextrinAthens Insomnia Scale AIS: After four weeks, AIS sleep symptoms decreased by 0.95 points more than with placebo when pooling the 20 and 30 mg/day Safr’Inside groups. Single-item Sleep Quality Scale SQS: After four weeks, self-rated SQS sleep quality was 1.02 points higher with 20 mg/day Safr’Inside than with placebo. Single-item Sleep Quality Scale SQS: After four weeks, self-rated SQS sleep quality was 0.82 points higher with 30 mg/day Safr’Inside than with placebo.
Effect of saffron extract supplementation on mood in healthy adults with subclinical symptoms of depression: a randomized, double-blind placebo-controlled study. ↗randomized_trialMood, anxiety and fatigue with mild symptoms51 adults with subclinical depressive symptomsActiv’Inside extract, >2.5% crocins and >1.5% safranal by the stated different analytical methods; 15 mg twice/day with breakfast and dinner; 6 weeks; comparison: MaltodextrinMood, anxiety and fatigue with mild symptoms: Activ’Inside showed no advantage over placebo in the overall score for low mood, anxiety and fatigue or its individual components. No significant between-group difference was shown for the composite or its individual components.